{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T21:03:41Z","timestamp":1765487021498,"version":"build-2065373602"},"reference-count":31,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"internal Lawrence Livermore National Laboratory Directed Research and Development funds","award":["17-LW-038","22-ERD-038"],"award-info":[{"award-number":["17-LW-038","22-ERD-038"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Rift Valley fever phlebovirus (RVFV) is a highly pathogenic mosquito-borne virus with bioweapon potential due to its ability to be spread by aerosol transmission. Neurological symptoms are among the worst outcomes of infection, and understanding of pathogenesis mechanisms within the brain is limited. RVFV is classified as an overlap select agent by the CDC and USDA; therefore, experiments involving fully virulent strains of virus are tightly regulated. Here, we present two methods for inactivation of live virus within samples derived from mouse microglia cells using commercially available kits for the preparation of cells for flow cytometry and RNA extraction. Using the flow cytometry protocol, we demonstrate key differences in the response of primary murine microglia to infection with fully virulent versus attenuated RVFV.<\/jats:p>","DOI":"10.3390\/pathogens13020159","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T03:50:27Z","timestamp":1707709827000},"page":"159","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of Inactivation Methods for Rift Valley Fever Virus in Mouse Microglia"],"prefix":"10.3390","volume":"13","author":[{"given":"Margarita V.","family":"Rangel","sequence":"first","affiliation":[{"name":"Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feliza A.","family":"Bourguet","sequence":"additional","affiliation":[{"name":"Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn I.","family":"Hall","sequence":"additional","affiliation":[{"name":"Environment, Safety & Health, Biosafety & Biogovernance Functional Area, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7618-4702","authenticated-orcid":false,"given":"Dina R.","family":"Weilhammer","sequence":"additional","affiliation":[{"name":"Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,10]]},"reference":[{"key":"ref_1","first-page":"e9674","article-title":"Molecular Biology and Epidemiology of Neurotropic Viruses","volume":"12","author":"Abdullahi","year":"2020","journal-title":"Cureus"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nature22402","article-title":"Zika virus evolution and spread in the Americas","volume":"546","author":"Metsky","year":"2017","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Azar, S.R., Campos, R.K., Bergren, N.A., Camargos, V.N., and Rossi, S.L. (2020). Epidemic Alphaviruses: Ecology, Emergence and Outbreaks. Microorganisms, 8.","DOI":"10.3390\/microorganisms8081167"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/vetres\/2010033","article-title":"Rift Valley fever virus(Bunyaviridae: Phlebovirus): An update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention","volume":"41","author":"Pepin","year":"2010","journal-title":"Vet. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3201\/eid0704.017401","article-title":"West Nile virus: A reemerging global pathogen","volume":"7","author":"Petersen","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1017\/S0950268810001020","article-title":"Rift Valley fever in Kenya: History of epizootics and identification of vulnerable districts","volume":"139","author":"Murithi","year":"2010","journal-title":"Epidemiol. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/378747","article-title":"Rift Valley Fever Epidemic in Saudi Arabia: Epidemiological, Clinical, and Laboratory Characteristics","volume":"37","author":"Madani","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ophtha.2004.09.018","article-title":"Ocular complications of Rift Valley fever outbreak in Saudi Arabia","volume":"112","author":"Abboud","year":"2005","journal-title":"Ophthalmology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1086\/345671","article-title":"Epidemic Rift Valley Fever in Saudi Arabia: A Clinical Study of Severe Illness in Humans","volume":"36","author":"Ayoola","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","unstructured":"Centers for Disease Control and Prevention (CDC), and Department of Health and Human Services (HHS) (2017). Possession, Use, and Transfer of Select Agents and Toxins; Biennial Review of the List of Select Agents and Toxins and Enhanced Biosafety Requirements. Final rule. Fed. Regist., 82, 6278\u20136294."},{"key":"ref_11","unstructured":"(2023, November 27). Guidance on the Inactivation or Removal of Select Agents and Toxins for Future Use, Available online: https:\/\/www.selectagents.gov\/compliance\/guidance\/inactivation\/index.htm."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.1128\/JVI.00135-15","article-title":"Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments","volume":"89","author":"Ikegami","year":"2015","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hum, N.R., Bourguet, F.A., Sebastian, A., Lam, D., Phillips, A.M., Sanchez, K.R., Rasley, A., Loots, G.G., and Weilhammer, D.R. (2022). MAVS mediates a protective immune response in the brain to Rift Valley fever virus. PLoS Pathog., 18.","DOI":"10.1371\/journal.ppat.1010231"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0165-5728(02)00187-X","article-title":"Borrelia burgdorferi induces inflammatory mediator production by murine microglia","volume":"130","author":"Rasley","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/glia.10034","article-title":"Expression of functional NK-1 receptors in murine microglia","volume":"37","author":"Rasley","year":"2002","journal-title":"Glia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1128\/JVI.00543-16","article-title":"A Genome-Wide RNA Interference Screen Identifies a Role for Wnt\/\u03b2-Catenin Signaling during Rift Valley Fever Virus Infection","volume":"90","author":"Harmon","year":"2016","journal-title":"J. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"12954","DOI":"10.1128\/JVI.02242-12","article-title":"Rift Valley Fever Virus Strain MP-12 Enters Mammalian Host Cells via Caveola-Mediated Endocytosis","volume":"86","author":"Harmon","year":"2012","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jneumeth.2014.05.021","article-title":"A novel cell line from spontaneously immortalized murine microglia","volume":"233","author":"Kulas","year":"2014","journal-title":"J. Neurosci. Methods"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1039\/C6IB00126B","article-title":"Differential regulation of NSC phenotype and genotype by chronically activated microglia within cocultures","volume":"8","author":"Farrell","year":"2016","journal-title":"Integr. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12974-018-1241-2","article-title":"Role of MCP-1 and CCR2 in ethanol-induced neuroinflammation and neurodegeneration in the developing brain","volume":"15","author":"Zhang","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1021\/acschemneuro.9b00694","article-title":"Multitarget Profiling of a Strigolactone Analogue for Early Events of Alzheimer\u2019s Disease: In Vitro Therapeutic Activities against Neuroinflammation","volume":"11","author":"Kurt","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Dave, K.M., Ali, L., and Manickam, D.S. (2020). Characterization of the SIM-A9 cell line as a model of activated microglia in the context of neuropathic pain. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0231597"},{"key":"ref_23","unstructured":"Payne, S. (2017). Viruses, Academic Press."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"27670","DOI":"10.1038\/srep27670","article-title":"Microglia retard dengue virus-induced acute viral encephalitis","volume":"6","author":"Tsai","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e00525-18","DOI":"10.1128\/JVI.00525-18","article-title":"Pharmacologic Depletion of Microglia Increases Viral Load in the Brain and Enhances Mortality in Murine Models of Flavivirus-Induced Encephalitis","volume":"92","author":"Seitz","year":"2018","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1172\/JCI97229","article-title":"Microglia are required for protection against lethal coronavirus encephalitis in mice","volume":"128","author":"Wheeler","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_27","first-page":"e55781","article-title":"Analysis of Microglia and Monocyte-derived Macrophages from the Central Nervous System by Flow Cytometry","volume":"124","author":"Martin","year":"2017","journal-title":"J. Vis. Exp. JoVE"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Thiel, N., Keyser, K.A., Lemmermann, N.A.W., Oduro, J.D., Wagner, K., Elsner, C., Halenius, A., Rovi\u0161, T.L., Brinkmann, M.M., and Jonji\u0107, S. (2016). The Mouse Cytomegalovirus Gene m42 Targets Surface Expression of the Protein Tyrosine Phosphatase CD45 in Infected Macrophages. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1006057"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e01628-20","DOI":"10.1128\/JVI.01628-20","article-title":"The Roseoloviruses Downregulate the Protein Tyrosine Phosphatase PTPRC (CD45)","volume":"95","author":"Whyte","year":"2021","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"E4884","DOI":"10.1073\/pnas.1312420110","article-title":"A unique secreted adenovirus E3 protein binds to the leukocyte common antigen CD45 and modulates leukocyte functions","volume":"110","author":"Windheim","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3390\/v7031540","article-title":"Viral Interference with Functions of the Cellular Receptor Tyrosine Phosphatase CD45","volume":"7","author":"Thiel","year":"2015","journal-title":"Viruses"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/13\/2\/159\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:58:15Z","timestamp":1760104695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/13\/2\/159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,10]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["pathogens13020159"],"URL":"https:\/\/doi.org\/10.3390\/pathogens13020159","relation":{},"ISSN":["2076-0817"],"issn-type":[{"type":"electronic","value":"2076-0817"}],"subject":[],"published":{"date-parts":[[2024,2,10]]}}}